Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Vastra Gotaland Region
Seagen Inc.
Genmab
KaliVir Immunotherapeutics
Fudan University
Tango Therapeutics, Inc.
Beijing Biotech
IDEAYA Biosciences
Vivace Therapeutics, Inc
AstraZeneca
iOnctura
Sotio Biotech Inc.
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Endeavor Biomedicines, Inc.
Nuvectis Pharma, Inc.
A2 Biotherapeutics Inc.
Zhejiang University
National Institutes of Health Clinical Center (CC)
University of Chicago
University Hospital, Lille
Royal Marsden NHS Foundation Trust
PrECOG, LLC.
Takeda
Lumicell, Inc.
Perspective Therapeutics
Seagen Inc.
Dana-Farber Cancer Institute
Novartis
Fundación GECP
Kezar Life Sciences, Inc.
H. Lee Moffitt Cancer Center and Research Institute
VM Oncology, LLC
Dana-Farber Cancer Institute
Bristol-Myers Squibb
NeoTX Therapeutics Ltd.
HiFiBiO Therapeutics
Brigham and Women's Hospital
Dana-Farber Cancer Institute
Ipsen
Brigham and Women's Hospital
Incyte Corporation
Actym Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine